ACD Marks Milestones for RNAscope In Situ Hybridization Technology
ACD’s easy-to-use RNAscope technology involved in more than 100 peer-reviewed papers in three years; company’s library of target probes exceeds 4,000.
Read MorePosted by Steve Halasey | Jul 21, 2014 | Molecular Diagnostics |
ACD’s easy-to-use RNAscope technology involved in more than 100 peer-reviewed papers in three years; company’s library of target probes exceeds 4,000.
Read MorePosted by Jenny Lower | Jun 13, 2014 | Sexually Transmitted Diseases |
Expert guidelines for initially confirming HIV infection are changing this year, moving away from dependence upon Western blot and emphasizing more practical, rapid tests.
Read MorePosted by Jenny Lower | Jun 13, 2014 | Sexually Transmitted Diseases |
Screening for sexually transmitted diseases is bringing a hidden epidemic into the spotlight. It’s also critical to keeping tabs on antimicrobial resistance.
Read MorePosted by Jenny Lower | Jun 9, 2014 | Rapid Assays |
With quick test results come public health benefits and better treatment, but for some rapid diagnostic tests, accuracy remains elusive.
Read MorePosted by Jenny Lower | Apr 17, 2014 | Cancer |
Technologies rarely advance at a steady and predictable pace, but new platforms and newer ideas are already shaping the future of clinical lab testing. This article from the April 2014 issue highlights a handful of companies that are working to bring new diagnostic technologies to market and improve patient care.
Read More